At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LGVN Longeveron Inc
Closed 11-19 16:00:00 EST
1.82
-0.10
-5.21%
盘后1.82
+0.000.00%
18:37 EST
High1.96
Low1.78
Vol14.87K
Open1.96
D1 Closing1.92
Amplitude9.38%
Mkt Cap5.92M
Tradable Cap4.41M
Total Shares3.25M
T/O27.82K
T/O Rate0.61%
Tradable Shares2.42M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Longeveron Q3 Revenue Falls 16% on Absence of Contract Manufacturing
Longeveron Announces Updated Results from Elpis Ii Phase 2B Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (Hlhs)
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, a candidate in Phase 2a/b trials that is used for the treatment of alzheimer's disease, hypoplastic left heart syndrome, and aging-related frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.